Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rigshospitalet, Denmark
Consorci Sanitari de Terrassa
AstraZeneca
Wake Forest University Health Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Innovent Biologics (Suzhou) Co. Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Arbele Limited
National Cancer Institute (NCI)
Chinese University of Hong Kong
National Cancer Institute (NCI)
AstraZeneca
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center Eugene Marquis
National Cancer Institute (NCI)
AstraZeneca
China Medical University Hospital
Odense University Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Northwell Health
Mayo Clinic
Zhongda Hospital
Nanjing Medical University
First Hospital of China Medical University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
Washington University School of Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
National Cancer Institute (NCI)
Centre Oscar Lambret
Hull University Teaching Hospitals NHS Trust